The European Medicines Agency’s (EMA) safety committee has added another blood condition to the potential side effects of AstraZeneca’s vaccine branded as Covishield in India - the Capillary Leak Syndrome.
The EMA’s addition of the syndrome to its list of potential side effects for the AstraZeneca Covid-19 jab comes as the regulator also examines reports of heart inflammation in recipients of the vaccine.
Capillary leak syndrome is a condition that causes fluid to leak out o...
